• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腰臀比与乳腺癌死亡率。

Waist-to-hip ratio and breast cancer mortality.

作者信息

Borugian Marilyn J, Sheps Samuel B, Kim-Sing Charmaine, Olivotto Ivo A, Van Patten Cheri, Dunn Bruce P, Coldman Andrew J, Potter John D, Gallagher Richard P, Hislop T Gregory

机构信息

Cancer Control Research Program, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

出版信息

Am J Epidemiol. 2003 Nov 15;158(10):963-8. doi: 10.1093/aje/kwg236.

DOI:10.1093/aje/kwg236
PMID:14607804
Abstract

High insulin levels have been associated with increased risk of breast cancer and poorer survival after a breast cancer diagnosis. Waist-to-hip ratio (WHR) is a marker for insulin resistance and hyperinsulinemia. In this study, the authors tested the hypothesis that elevated WHR is directly related to breast cancer mortality. For identification of modifiable factors affecting survival, data were collected on 603 patients with incident breast cancer who visited the Vancouver Cancer Centre of the British Columbia Cancer Agency (Vancouver, British Columbia, Canada) in 1991-1992, including body measurements and information on demographic, medical, reproductive, and dietary factors. These patients were followed for up to 10 years. Cox proportional hazards regression models were used to relate the variables to breast cancer mortality (n = 112). After adjustment for age, body mass index, family history, estrogen receptor (ER) status, tumor stage at diagnosis, and systemic treatment (chemotherapy or tamoxifen), WHR was directly related to breast cancer mortality in postmenopausal women (for highest quartile vs. lowest, relative risk = 3.3, 95% confidence interval: 1.1, 10.4) but not in premenopausal women (relative risk = 1.2, 95% confidence interval: 0.4, 3.4). Stratification according to ER status showed that the increased mortality was restricted to ER-positive postmenopausal women. Elevated WHR was confirmed as a predictor of breast cancer mortality, with menopausal status and ER status at diagnosis found to be important modifiers of that relation.

摘要

高胰岛素水平与乳腺癌风险增加及乳腺癌诊断后较差的生存率相关。腰臀比(WHR)是胰岛素抵抗和高胰岛素血症的一个指标。在本研究中,作者检验了这样一个假设,即升高的WHR与乳腺癌死亡率直接相关。为了确定影响生存的可改变因素,收集了1991年至1992年期间前往不列颠哥伦比亚癌症机构温哥华癌症中心(加拿大不列颠哥伦比亚省温哥华)就诊的603例新发乳腺癌患者的数据,包括身体测量数据以及人口统计学、医学、生殖和饮食因素方面的信息。对这些患者进行了长达10年的随访。采用Cox比例风险回归模型将变量与乳腺癌死亡率(n = 112)相关联。在调整了年龄、体重指数、家族史、雌激素受体(ER)状态、诊断时的肿瘤分期和全身治疗(化疗或他莫昔芬)后,WHR与绝经后女性的乳腺癌死亡率直接相关(最高四分位数与最低四分位数相比,相对风险 = 3.3,95%置信区间:1.1,10.4),但与绝经前女性无关(相对风险 = 1.2,95%置信区间:0.4,3.4)。根据ER状态分层显示,死亡率增加仅限于ER阳性的绝经后女性。升高的WHR被确认为乳腺癌死亡率的一个预测指标,发现绝经状态和诊断时的ER状态是该关系的重要调节因素。

相似文献

1
Waist-to-hip ratio and breast cancer mortality.腰臀比与乳腺癌死亡率。
Am J Epidemiol. 2003 Nov 15;158(10):963-8. doi: 10.1093/aje/kwg236.
2
Insulin, macronutrient intake, and physical activity: are potential indicators of insulin resistance associated with mortality from breast cancer?胰岛素、常量营养素摄入与身体活动:它们是与乳腺癌死亡率相关的胰岛素抵抗潜在指标吗?
Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1163-72.
3
Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case-Control Study in Northern and Eastern China and Implications for Chemoprevention.体质指数和腰臀比联合雌孕激素受体状态对中国北方和东部地区乳腺癌发病风险的影响:病例对照研究结果及其对化学预防的意义。
Oncologist. 2017 Dec;22(12):1431-1443. doi: 10.1634/theoncologist.2017-0148. Epub 2017 Sep 14.
4
Body-size indicators and risk of breast cancer according to menopause and estrogen-receptor status.根据绝经状态和雌激素受体状态的身体大小指标与乳腺癌风险
Int J Cancer. 1996 Sep 27;68(1):8-13. doi: 10.1002/(SICI)1097-0215(19960927)68:1<8::AID-IJC2>3.0.CO;2-V.
5
Hip circumference is associated with the risk of premenopausal ER-/PR- breast cancer.臀围与绝经前 ER-/PR- 乳腺癌风险相关。
Int J Obes (Lond). 2012 Mar;36(3):431-9. doi: 10.1038/ijo.2011.66. Epub 2011 Mar 22.
6
Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.体型、身体活动与乳腺癌激素受体状态:两项病例对照研究的结果
Cancer Epidemiol Biomarkers Prev. 2000 Jul;9(7):681-7.
7
Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.胰岛素、胰岛素样生长因子-I与绝经后女性患乳腺癌的风险
J Natl Cancer Inst. 2009 Jan 7;101(1):48-60. doi: 10.1093/jnci/djn415. Epub 2008 Dec 30.
8
Body fat distribution and obesity in pre- and postmenopausal breast cancer.绝经前和绝经后乳腺癌患者的体脂分布与肥胖情况
Int J Epidemiol. 1999 Dec;28(6):1026-31. doi: 10.1093/ije/28.6.1026.
9
Body weight correlates with mortality in early-stage breast cancer.体重与早期乳腺癌的死亡率相关。
Arch Surg. 2004 Sep;139(9):954-58; discussion 958-60. doi: 10.1001/archsurg.139.9.954.
10
General and abdominal obesity and survival among young women with breast cancer.年轻乳腺癌女性的全身及腹部肥胖与生存情况
Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1871-7. doi: 10.1158/1055-9965.EPI-06-0356.

引用本文的文献

1
Impact of body mass index on pathological response after neoadjuvant chemotherapy: results from the I-SPY 2 trial.新辅助化疗后体重指数对病理反应的影响:来自 I-SPY 2 试验的结果。
Breast Cancer Res Treat. 2024 Apr;204(3):589-597. doi: 10.1007/s10549-023-07214-5. Epub 2024 Jan 12.
2
Leptin and leptin receptor expression as biomarkers for breast cancer: a retrospective study.瘦素和瘦素受体表达作为乳腺癌的生物标志物:一项回顾性研究。
BMC Cancer. 2023 Mar 20;23(1):260. doi: 10.1186/s12885-023-10617-8.
3
Postdiagnosis body fatness, weight change and breast cancer prognosis: Global Cancer Update Program (CUP global) systematic literature review and meta-analysis.
诊断后体脂肪、体重变化与乳腺癌预后:全球癌症更新计划(CUP global)系统文献回顾与荟萃分析。
Int J Cancer. 2023 Feb 15;152(4):572-599. doi: 10.1002/ijc.34322. Epub 2022 Oct 24.
4
The effect of obesity on adipose-derived stromal cells and adipose tissue and their impact on cancer.肥胖对脂肪来源的基质细胞和脂肪组织的影响及其对癌症的影响。
Cancer Metastasis Rev. 2022 Sep;41(3):549-573. doi: 10.1007/s10555-022-10063-1. Epub 2022 Aug 24.
5
Adiposity and cancer survival: a systematic review and meta-analysis.肥胖与癌症生存:系统评价和荟萃分析。
Cancer Causes Control. 2022 Oct;33(10):1219-1246. doi: 10.1007/s10552-022-01613-7. Epub 2022 Aug 15.
6
Insulin and cancer: a tangled web.胰岛素与癌症:错综复杂。
Biochem J. 2022 Mar 18;479(5):583-607. doi: 10.1042/BCJ20210134.
7
Lipofilling in Breast Oncological Surgery: A Safe Opportunity or Risk for Cancer Recurrence?乳房肿瘤外科中的脂肪移植:癌症复发的安全机会还是风险?
Int J Mol Sci. 2021 Apr 3;22(7):3737. doi: 10.3390/ijms22073737.
8
Endocrine Therapy-related Endocrinopathies-Biology, Prevalence and Implications for the Management of Breast Cancer.内分泌治疗相关的内分泌病——生物学、患病率及对乳腺癌管理的影响
Oncol Hematol Rev. 2020 Spring;16(1):17-22. doi: 10.17925/ohr.2020.16.1.17. Epub 2020 Feb 16.
9
Relationship of breast volume, obesity and central obesity with different prognostic factors of breast cancer.乳房体积、肥胖和中心型肥胖与乳腺癌不同预后因素的关系。
Sci Rep. 2021 Jan 21;11(1):1872. doi: 10.1038/s41598-021-81436-9.
10
Impact of body mass index on pathological complete response following neoadjuvant chemotherapy in operable breast cancer: a meta-analysis.体质量指数对可手术乳腺癌新辅助化疗后病理完全缓解的影响:一项荟萃分析。
Breast Cancer. 2021 May;28(3):618-629. doi: 10.1007/s12282-020-01194-w. Epub 2021 Jan 2.